Regeneron's PD-1 inhibitor Libtayo could find wider use for a form of skin cancer known as cutaneous squamous cell carcinoma after showing efficacy in a pivotal trial as adjuvant therapy for patients ...
On the Media is a weekly show that uses the media as a lens to understand our world. On the Media listeners say the show is an essential companion, helping them survive the firehose of media coming at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback